{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:22:29Z","timestamp":1784164949284,"version":"3.55.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s10620-022-07607-4","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T13:02:53Z","timestamp":1656939773000},"page":"897-901","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative Colitis"],"prefix":"10.1007","volume":"68","author":[{"given":"Nathaniel A.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Setia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushila","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Pekow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2864-1670","authenticated-orcid":false,"given":"Dejan","family":"Micic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"key":"7607_CR1","doi-asserted-by":"publisher","first-page":"S701","DOI":"10.1093\/clinids\/12.Supplement_7.S701","volume":"12","author":"M Ho","year":"1990","unstructured":"Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis. 1990;12:S701\u2013S710.","journal-title":"Rev Infect Dis."},{"key":"7607_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S2468-1253(16)30159-5","volume":"2","author":"B Siegmund","year":"2017","unstructured":"Siegmund B. Cytomegalovirus infection associated with inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2017;2:369\u2013376.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"7607_CR3","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.3748\/wjg.v20.i10.2695","volume":"20","author":"U Kopylov","year":"2014","unstructured":"Kopylov U et al. Antiviral therapy in cytomegalovirus-positive ulcerative colitis: a systematic review and meta-analysis. World J Gastroenterol. 2014;20:2695.","journal-title":"World J Gastroenterol."},{"key":"7607_CR4","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1097\/MIB.0000000000000489","volume":"21","author":"T Shukla","year":"2015","unstructured":"Shukla T, Singh S, Loftus EV, Bruining DH, McCurdy JD. Antiviral therapy in steroid-refractory ulcerative colitis with cytomegalovirus: systematic review and meta-analysis. Inflamm Bowel Dis. 2015;21:2718\u20132725.","journal-title":"Inflamm Bowel Dis."},{"key":"7607_CR5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.cgh.2014.09.042","volume":"13","author":"A Jones","year":"2015","unstructured":"Jones A et al. Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy forcytomegalovirus. Clin Gastroenterol Hepatol. 2015;13:949\u2013955.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7607_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/ecco-jcc\/jjy173","volume":"13","author":"A Clos-Parals","year":"2019","unstructured":"Clos-Parals A et al. Prognostic value of the burden of cytomegalovirus colonic reactivation evaluated by immunohistochemical staining in patients with active ulcerative colitis. J. Crohn\u2019s Colitis 2019;13:385\u2013388.","journal-title":"J. Crohn\u2019s Colitis"},{"key":"7607_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/ecco-jcc\/jjw071","volume":"10","author":"E Zag\u00f3rowicz","year":"2016","unstructured":"Zag\u00f3rowicz E et al. Cytomegalovirus infection in ulcerative colitis is related to severe inflammation and a high count of cytomegalovirus-positive cells in biopsy is a risk factor for colectomy. J. Crohn\u2019s Colitis 2016;10:1205\u20131211.","journal-title":"J. Crohn\u2019s Colitis"},{"key":"7607_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","volume":"114","author":"DT Rubin","year":"2019","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114:384\u2013413.","journal-title":"Am. J. Gastroenterol."},{"key":"7607_CR9","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1097\/MIB.0000000000000412","volume":"21","author":"S Pillet","year":"2015","unstructured":"Pillet S et al. Infliximab does not worsen outcomes during flare-ups associated with cytomegalovirus infection in patients with ulcerative colitis. Inflamm Bowel Dis. 2015;21:1580\u20131586.","journal-title":"Inflamm Bowel Dis."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07607-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07607-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07607-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T05:14:07Z","timestamp":1678684447000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07607-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["7607"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07607-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,4]]},"assertion":[{"value":"10 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NAC, NS, MZ, MJA and DM: no conflicts of interest. DTR: Received grant support from Takeda; and has served as a consultant for\u00a0Abbvie,\u00a0Abgenomics, Allergan Inc., Arena Pharmaceuticals, Bellatrix Pharmaceuticals,\u00a0Boehringer\u00a0Ingelheim\u00a0Ltd., Bristol-Myers Squibb, Celgene Corp\/Syneos, Check-cap,\u00a0Dizal\u00a0Pharmaceuticals,\u00a0GalenPharma\/Atlantica, Genentech\/Roche, Gilead Sciences,\u00a0Ichnos\u00a0Sciences S.A.,\u00a0InDex\u00a0Pharmaceuticals, Iterative Scopes, Janssen Pharmaceuticals, Lilly,\u00a0Materia\u00a0Prima, Narrow River\u00a0Mgmt, Pfizer, Prometheus Laboratories,Reistone, Takeda, and\u00a0Techlab\u00a0Inc. He is also co-founder of Cornerstones Health, Inc. and\u00a0GoDuRn, LLC; on the Board of Trustees of the American College of Gastroenterology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}